Revvity reported $626.22M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Align Technology USD 822.85M 11.8M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Celltrion KRW 724.99B 6B Sep/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.13B 32.4M Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Pharma Mar EUR 39.62M 7.34M Sep/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 176.13M 279K Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Waters USD 661.85M 1.67B Dec/2025
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025